{
    "clinical_study": {
        "@rank": "94219", 
        "acronym": "PRIMO_Social", 
        "arm_group": [
            {
                "arm_group_label": "Education - Diabetes and Social Issues", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized to this arm, will participate immediately in the education module \"Diabetes and Social Issues\""
            }, 
            {
                "arm_group_label": "Waiting-list control group", 
                "arm_group_type": "No Intervention", 
                "description": "Patients in the control group will get the education with the education module after completion of the 6-month follow-up"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a multi-center, randomized prospective trial with a 6-month follow up. A newly\n      developed treatment and education module will be tested compared to a waiting-list control\n      group. The module covers the topic \"diabetes and social issues\". Primary outcome variable is\n      diabetes-specific empowerment regarding diabetes and social issues. Secondary outcome\n      variables are: diabetes-related distress, health-related quality of life, depressive\n      symptoms, self-care behavior, and glycemic control."
        }, 
        "brief_title": "Diabetes and Social Issues: Evaluation of a Diabetes Education Module", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "detailed_description": {
            "textblock": "The module consists of one lesson (duration: 90 minutes). The module is derived from the\n      empowerment approach and is based on the previously evaluated education and treatment\n      program for type 1 diabetes: PRIMAS (NCT01220557). The module is designed as a group session\n      held by a trained diabetes educator. Patients are randomized either to the immediate\n      participation in the module or to the control group. Control group is a waiting-list control\n      group. Patients in this waiting-list control group get the education after the completion of\n      the 6-month follow-up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Intensive insulin treatment\n\n          -  specific interest in \"Diabetes and Social Issues\"\n\n          -  wish to participate in group education\n\n          -  informed consent\n\n          -  fluent in reading and speaking German language\n\n        Exclusion Criteria:\n\n          -  diabetes duration < 4 week\n\n          -  severe organic disease (e.g. terminal renal disease, cancer with poor prognosis)\n\n          -  current treatment of a mental disease\n\n          -  cognitive impairment\n\n          -  dementia\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02076555", 
            "org_study_id": "NH022014_3"
        }, 
        "intervention": {
            "arm_group_label": "Education - Diabetes and Social Issues", 
            "description": "Based on the treatment and education programme PRIMAS a problem-specific education module regarding \"Diabetes and Social Issues\" was created. The module covers specific and detailed aspects of the topic \"social issues\" such as driver licence, hypoglycemia when driving, and the pass for severly handicapped persons. With this module, a more comprehensive education of patients with specific interest is possible.", 
            "intervention_name": "Education - Diabetes and Social Issues", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "diabetes", 
            "education", 
            "randomized", 
            "prospective"
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": [
            {
                "contact": {
                    "email": "hermanns@diabetes-zentrum.de", 
                    "last_name": "Norbert Hermanns, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bad Mergentheim", 
                        "country": "Germany", 
                        "zip": "97980"
                    }, 
                    "name": "Research Institute of the Diabetes Academy Mergentheim (FIDAM)"
                }, 
                "investigator": [
                    {
                        "last_name": "Bernhard Kulzer, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Nikola Bergis-Jurgan, MSc", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dominic Ehrmann, MSc", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "diabeteszentrumhamburg@t-online.de", 
                    "last_name": "Jens Kr\u00f6ger, M.D."
                }, 
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "21029"
                    }, 
                    "name": "Zentrum f\u00fcr Diabetologie Bergedorf"
                }, 
                "investigator": {
                    "last_name": "Jens Kr\u00f6ger, M.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kontakt@diabeteszentrum-ludwigsburg.de", 
                    "last_name": "J\u00f6rg Gloyer, M.D"
                }, 
                "facility": {
                    "address": {
                        "city": "Ludwigsburg", 
                        "country": "Germany", 
                        "zip": "71634"
                    }, 
                    "name": "Diabeteszentrum Ludwigsburg"
                }, 
                "investigator": {
                    "last_name": "J\u00f6rg Gloyer, M.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@dr-betzholz.de", 
                    "last_name": "Rainer Betzholz, M.D"
                }, 
                "facility": {
                    "address": {
                        "city": "Neuss", 
                        "country": "Germany", 
                        "zip": "41462"
                    }, 
                    "name": "Diabetologische Schwerpunktpraxis Neuss"
                }, 
                "investigator": {
                    "last_name": "Rainer Betzholz, M.D", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Multi-center Evaluation of a Diabetes Education Module Specifically Addressing the Topic \"Diabetes and Social Issues\" in a Randomized Controlled Trial", 
        "overall_contact": {
            "email": "hermanns@diabetes-zentrum.de", 
            "last_name": "Norbert Hermanns, PhD", 
            "phone": "0049 7931 594 553"
        }, 
        "overall_official": {
            "affiliation": "Forschungsinstitut der Diabetes Akademie Mergentheim", 
            "last_name": "Norbert Hermanns, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The Diabetes Empowerment Scale was specifically adjusted to cover the topic \"social issues\". Psychometric criteria for these adjusted scale were evaluated in an independent study", 
            "measure": "Change from baseline in diabetes-specific empowerment on the adapted Diabetes Empowerment Scale at the 2-week and 6-month follow-up", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 2-week follow-up , 6-month follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02076555"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Forschungsinstitut der Diabetes Akademie Mergentheim", 
            "investigator_full_name": "Norbert Hermanns", 
            "investigator_title": "Head of the Research Institut Diabetes Academy Mergentheim", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The PAID scale was specifically adapted to cover the topic \"social issues\". Psychometric quality was assessed in an independent study", 
                "measure": "Change from baseline in problem-specific distress on the adapted Problem Areas in Diabetes (PAID) Scale at the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }, 
            {
                "description": "HbA1c will be analyzed in a central laboratory.", 
                "measure": "Change from baseline in glycemic control (HbA1c) at the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }, 
            {
                "measure": "Change from baseline in health-related quality of life on the EQ-5D at the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }, 
            {
                "measure": "Change from baseline in quality of life on the WHO-5 at the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }, 
            {
                "measure": "Change from baseline in self-efficacy on the General Self-Efficacy Scale (GSE) the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }, 
            {
                "measure": "Change from baseline in general diabetes-distress at the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }, 
            {
                "measure": "Change from baseline in depressive symptoms on the CES-D at the 2-week and 6-month follow-up", 
                "safety_issue": "No", 
                "time_frame": "baseline, 2-week follow-up, 6-month follow-up"
            }
        ], 
        "source": "Forschungsinstitut der Diabetes Akademie Mergentheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Forschungsinstitut der Diabetes Akademie Mergentheim", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}